Drug Approval | November 17, 2021
Alembic JV receives final approval for Mupirocin cream
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
Launching in 2022, its availability will be expanded to the global market
Vakrangee’s distribution network across rural India will help penetrate underserved markets
The group now has 324 approvals and has so far filed over 400 ANDAs
The company performed particularly well in operational eco-efficiency, environmental and social reporting
The Board of Directors of Alembic Pharmaceuticals have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021.
Glycopyrrolate injection can also be used in adults as an adjunctive therapy for the treatment of gastrointestinal ulcer when a rapid effect is desired or when oral medication is not tolerated
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
The injunction order has been passed against Natco Pharma, Torrent Pharmaceuticals, Eris Lifesciences and Windlas Biotech
Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.
Subscribe To Our Newsletter & Stay Updated
